W. Schmid‐Burgk

1.3k citations
18 papers · 976 indexed · 1 hit paper · h-index 12
Topics
Treatment of Major Depression (7 papers)Neuroscience and Neuropharmacology Research (4 papers)Electroconvulsive Therapy Studies (4 papers)
Partner nations
SwitzerlandGermanyBrazil

In The Last Decade

W. Schmid‐Burgk

18 papers receiving 923 citations

Hit Papers

Low cerebrospinal fluid glutamate in schizophrenic patien...19802026199520101980100200300400500

Peers

W. Schmid‐Burgk
Comparison fields: 5 of 81
  • Cellular and Molecular Neuroscience 538
  • Psychiatry and Mental health 316
  • Molecular Biology 272
  • Biological Psychiatry 269
  • Pharmacology 241
Replace L. Bjerkenstedt with:
L. Bjerkenstedt Sweden
Monica M. Marcus Sweden
R Kawahara Japan
Stephen C. Berry United Kingdom
Akeo Kurumaji Japan
Jorge Pérez Italy
Danielle Abi‐Saab Switzerland
Don Goff United States
Carol J. Grossman United Kingdom
Robert Zöchling Germany
W. Schmid‐Burgk relative to L. Bjerkenstedt Sweden L. Bjerkenstedt's profile →
Citations per field
00.5×1.5×
L. Bjerkenstedt · 1×
Citations per year

Countries citing papers authored by W. Schmid‐Burgk

Since Specialization
Citations

This map shows the geographic impact of W. Schmid‐Burgk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Schmid‐Burgk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Schmid‐Burgk more than expected).

Fields of papers citing papers by W. Schmid‐Burgk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Schmid‐Burgk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Schmid‐Burgk. The network helps show where W. Schmid‐Burgk may publish in the future.

Co-authorship network of co-authors of W. Schmid‐Burgk

This figure shows the co-authorship network connecting the top 25 collaborators of W. Schmid‐Burgk. A scholar is included among the top collaborators of W. Schmid‐Burgk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Schmid‐Burgk. W. Schmid‐Burgk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 11
2 1
3 19
4 27
5 37
6 8
7
Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
32
8 60
9
Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine.
16
10 2
11 2
12 22
13 48
14 13
15 133
16 5
17
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophreniabreakdown →
513
18 27

About W. Schmid‐Burgk

W. Schmid‐Burgk is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Pharmacology, having authored 18 papers that have together received 976 indexed citations. Recurring topics across this work include Treatment of Major Depression (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Electroconvulsive Therapy Studies (4 papers). The work is most often cited by research in Biological Psychiatry (269 citations), Cellular and Molecular Neuroscience (538 citations) and Behavioral Neuroscience (75 citations). W. Schmid‐Burgk has collaborated with scholars based in Switzerland, Germany and Brazil. Frequent co-authors include H. H. Kornhuber, Daniel Claus, R. Amrein, M. Stabl, R. Jürgens, Wolfgang Becker, V. Diekmann, Kathleen Bizière, W. Hetzel and Márcio Versiani. Their work appears in journals such as The British Journal of Psychiatry, Psychopharmacology and Acta Psychiatrica Scandinavica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026